Integra Lifesciences Holdings Corp (NAS:IART)
$ 29 0.1 (0.35%) Market Cap: 2.29 Bil Enterprise Value: 1.79 Bil PE Ratio: 58.00 PB Ratio: 0.79 GF Score: 77/100

Integra Lifesciences Holdings Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2020 / 02:30PM GMT
Release Date Price: $45.31 (+4.42%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

Well, good morning, everyone, and welcome to the Morgan Stanley Healthcare Conference. My name is David Lewis, medical device analyst here at Morgan Stanley. Thanks for being with us here on day 1 of our 5-day virtual event. It's my pleasure here, as we progress through the morning, to have with us Integra LifeSciences and their CEO, Peter Arduini. We're going to jump right into Q&A with Pete. But before I do, make sure you go to the Morgan Stanley website under research disclosures and check out fun facts about me.

Questions & Answers

David Ryan Lewis;Peter J. Arduini
Morgan Stanley, Research Division - MD;

So Pete, just I want to start this morning, kind of how we've been starting with a lot of companies here, obviously, with the topic de jure which is COVID. You talked about June being down around 13%. I just wonder -- can you just update us here on what kind of improvement you're seeing here in July, August and September relative to some of your peers.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot